The Bob Harrington ShowView all posts »
#38: HDL cholesterol, niacin, and AIM-HIGH with Dr Jim SteinJul 6, 2011 15:05 EDT
Is the concept of raising HDL cholesterol still pertinent in an era of well-controlled LDL levels via statin therapy? To address this question, our guest Dr Jim Stein reviews what evidence exists to indicate low HDL cholesterol may predict heart disease, how the drug niacin fits into the equation, and what the results of the AIM-HIGH trial might mean for this hypothesis.
Dr Stein has served on data and safety monitoring committees (not related to niacin) for Abbott, Lilly, and Takeda. He has received royalties (not related to dyslipidemia) from the Wisconsin Alumni Research Foundation.
For Dr Harrington's disclosures, click here.